Clinical Trial Update: Dose Finding Study of Bone Morphogenetic Protein 7 (BMP-7) in Subjects With Osteoarthritis (OA) of the Knee [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding study of Bone Morphogenetic Protein 7 (BMP-7) in knee osteoarthritis has completed, sponsored by Stryker Biotech.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Bone Morphogenetic Protein 7 (BMP-7) (bone morphogenetic protein-7)

Snippet

Sponsor: Stryker Biotech | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED